US2010331279A1PendingUtilityA1
Inhibition of Antigen Presentation with Poorly Catabolized Polymers
Est. expirySep 26, 2020(expired)· nominal 20-yr term from priority
A61K 39/001A61K 31/721A61K 31/715A61P 37/06A61K 39/00
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods to prevent the rejection of immunogenic tissues in an animal by administering a non-immunogenic, poorly catabolized molecule in an amount sufficient to inhibit an immune response are described herein. Also described are compositions that are useful for inhibiting immune responses in animals that are recipients of cellular transplants. For example, these methods and compositions can be used to prevent the rejection of xenografted and allografted tissues in an animal.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition comprising a poorly catabolized polymer wherein said poorly catabolized polymer is used to inhibit the presentation of at least one antigen to the immune system of an animal.
2 . The pharmaceutical composition of claim 1 , wherein said poorly catabolized polymer comprises a dextran solution.
3 . The pharmaceutical composition of claim 1 , wherein the antigen comprises a cell.
4 . The pharmaceutical composition of claim 1 , wherein said poorly catabolized polymer is dextran.Join the waitlist — get patent alerts
Track US2010331279A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.